Why Wall Street Is Piling Into the "Debasement Trade"
Wall Street has been making headlines lately for piling into a strange new money move. What they've dubbed the "Debasement Trade"... And it could affect you and your money in a MAJOR way. Dr. David Eifrig's latest warning deserves your attention.
Shares Stats
| Shares Outstanding | 3,159,200,000 |
| Shares Float | 3,159,190,000 |
| Shares Short | 8,870,000 |
| Insider Holdings | 1% |
| Institution Holdings | 2.50% |
About Takeda Pharmaceutical Co ADR
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived therapies, immunology, oncology, and neuroscience. The company provides its products under the Entyvio, Gattex/Revestive, Takecab/Vocinti, EOHILIA, Alofisel, Dexilant, Pantoloc/Controloc, Adynovate/Adynovi, Feiba, Recombinate, Hemofil/Immunate/Immunine, Takhzyro, Livtencity, ADZYNMA, Elaprase, Replagal, Advate, Flexbumin, Vpriv, Gammagard Liquid/Kiovig, Hyqvia, Cuvitru, Exkivity, FRUZAQLA, Ninlaro, Velcade, Azilva-F, Lotriga, Iclusig, Leuplin/Enantone, Adcetris, vyvanse/elvanse, Trintellix, QDENGA, and Alunbrig brands. It has in-license agreement with BioMarin, Luxna Biotech, GlaxoSmithKline, Halozyme, and Kamada; collaboration with Neurocrine Biosciences, Inc., Seagen Inc., Anima Biotech, Denali Therapeutics, KSQ Therapeutics, Noile-Immune Biotech, Center for iPS Cell Research Application, Kyoto University (CiRA), and Charles River Laboratories; licensing agreement with Mirum Pharmaceuticals and Twist Bioscience, UCSD/Fortis Advisors, PeptiDream, MD Anderson Cancer Center, Teva Pharmaceutical Industries, and Xenetic Biosciences; collaboration and licensing agreement with Arrowhead Pharmaceuticals Inc., Engitix, Genevant Sciences Corporation, Sosei Heptares, Zedira/Dr. Falk Pharma, Exelixis, Inc., GlaxoSmithKline, Heidelberg Pharma, HUTCHMED, Presage Biosciences, Codexis, Inc., Ensoma, Envozyne, KM Biologics, and Selecta BioScience, and Ovid Therapeutics Inc.; and collaboration with ZEDIRA GmbH and Dr. Falk Pharma GmbH. It has research collaboration and licensing agreement with Crescendo Biologics, Code Bio, Immusoft, Poseida Therapeutics, and Selecta Biosciences. The company was founded in 1781 and is headquartered in Tokyo, Japan.
General
| Name | Takeda Pharmaceutical Co ADR |
| Ticker | TAK |
| Exchange | NYSE |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| Currency | USD |
| Country | USA |
| Fiscal Year End | March |
| Full Time Employees | 47,455 |
Highlights
| Analyst Target | 16.29 |
| Market Cap | 44,987,000,000 |
| PE Ratio | 180.71 |
| PEG Ratio | 0.29 |
| EBITDA | 1,138,373,033,984 |
Financials
| Profit Margin | 0.87% |
| Operating Margin | 11.06 |
| Return on Assets | 0.02 |
| Return on Equity | 0.00 |
| Revenue | 29.6B |
| Earnings Per Share | 0.07 |
| Revenue Per Share | 1,400.91 |
| Gross Profit | 2,862,113,882,112 |
| Quarterly Revenue Growth | -0.05 |
Valuation
| Trailing PE | 201.29 |
| Forward PE | 9.17 |
| Price/Sales (Trailing 12 Mt.) | 0.01 |
| Price/Book (Most Recent Quarter) | 0.96 |
Dividend
Takeda Pharmaceutical Co ADR pays out a dividend of $0.66 per share, with a dividend yield of 4.62%.
TAK's last dividend payment was made to shareholders on July 7, 2025.
They pay out 242.25% of their earnings out as a dividend.
Recent Dividends
| Dec 31, 1969 | $0.32 |
| Jul 7, 2025 | $0.34 |
| Dec 12, 2024 | $0.33 |
| Jul 8, 2024 | $0.30 |
Tradr Expands Leveraged Lineup With 4 New Single-Stock ETFs Targeting AI Infrastructure Firms
The new ETFs offer 2x exposure to Bloom Energy, Celestica, NANO Nuclear Energy, and Synopsys—each linked to America's expanding AI infrastructure.
IRS boosts contribution limits for 401(k) retirement plan savers
Americans will be allowed to contribute more of their money to 401(k) and similar retirement saving plans next year.
This Overlooked Memecoin Is Showing Early Breakout Signals - Ad
We've been tracking one small memecoin that checks all the boxes: strong on-chain signals, real traction, and an entry point that could offer serious upside. It's not on many radars yet-but that could change fast.
Some Korean workers detained in Georgia immigration raid have returned to their jobs at Hyundai site
SAVANNAH, Ga. (AP) — Two months after 300 South Korean nationals were detained and left the U.S. following in an at Hyundai's electric vehicle manufacturing site in Georgia, some of those workers have returned to America to resume those jobs, their employer said Thursday.
California revokes 17,000 driver's licenses. But the state disputes it is over immigration concerns
California plans to revoke 17,000 commercial driver’s licenses given to immigrants after the Trump administration raised concerns about people in the country illegally receiving licenses to drive a semitruck or a bus. But Gov. Gavin Newsom said that isn't the reason.
Buy This Stock Tomorrow? - Ad
A renowned former hedge fund manager - friends to some of the biggest investors in the world - just released a new list of his favorite AI stocks... and not a single Magnificent 7 name made the cut. Instead, an AI stock you've likely never heard of just flagged as "near-perfect" in his new investing scoring system.
Gavin Newsom Won't 'Punch' Anyone In The Face, But Says He's 'Stunned' By Democrats Who Sided With GOP On Deal To Reopen Government
Gov. Newsom stunned by senators' surrender to reopen government. Calls out Trump for changing the rules of the game. Infighting in Dem party.
AutoZone's Domestic 'Do It For Me' Business Driving Market Share Gains
Goldman Sachs upgrades AutoZone to Buy after recent sell-off, highlighting double-digit domestic DIFM growth, share gains, and long-term EPS upside through FY28.
America's Next Security Revolution Has Begun - Ad
Built for endurance, powered by AI, and proven in the field, the K7 is redefining protection for ports, energy hubs, and cities across the nation. The rollout is already underway.
Congress Ended The Shutdown — But At The Cost Of Re-Criminalizing These THC Products In A Last-Minute Deal That Could Reshape The Cannabis Industry
Congress appears set to end the record-long government shutdown, but a controversial provision tucked into the spending bill is sparking alarm across the hemp and cannabis industry.
MSNBC's name is being replaced, but its leaders insist that its mission will remain the same
NEW YORK (AP) — Asked what viewers should expect when television's MSNBC makes its from NBC News final this weekend, network president Rebecca Kutler points to a poster on the wall of a conference room at its new offices off Times Square.
The New Gold Trade Dominating on Wall Street - Ad
Wall Street has been making headlines lately for piling into gold. According to Dr. David Eifrig, the gold bull run is just getting started. He says you should move your money to his No. 1 gold stock immediately (not a miner or ETF but it has 1,000% upside potential.)
From beaches to ski slopes, photos show how cameras keep watch all over China
BEIJING, China (AP) —
Huntington Bancshares buying Cadence Bank in $7.4 billion all-stock deal
Huntington Bancshares is buying regional bank Cadence Bank in an all-stock deal valued at $7.4 billion that will strengthen its position across the Southern U.S.
Another Gold High? Here's the Move Wall Street Is Missing ... - Ad
Gold just surged past $4,200, up 45% in a year - but Sean Brodrick says $6,900 could be next. History shows when gold booms, one hidden play has delivered far bigger gains - 21x, 49x, even 1,386x. The same strategy once handed 26,000% profits. And Sean says it's back on the table now.
This Undervalued Biotech Might Have Just Proven Its Star Drug's Staying Power
Apellis reports five-year Syfovre data showing up to 31% slower GA lesion growth, reinforcing strong long-term efficacy and analyst optimism.
Ford Expedition vs GMC Yukon, an Edmunds big SUV comparison
Let’s say you need a vehicle with room for more than five passengers, a large cargo area, and the ability to pull a heavy trailer. A full-size three-row SUV should work well, but which one? The most significant news this year is the redesigned . Ford has given its biggest SUV a complete makeover with a more upscale interior, new technology features and a novel split-opening tailgate.
Speculative? Yes. But This Memecoin Has Serious Fundamentals. - Ad
Most memecoins are driven by hype-but this one might be different. Backed by a real use case and unexpected investor interest, our analysts believe it could emerge as one of the strongest performers in the coming cycle.
A Vermont cycling apparel company is trying to survive Trump's tariffs. Will the Supreme Court help?
BURLINGTON, Vt. (AP) — From the moment President Donald Trump on nearly every country, Nik Holm feared the company he leads might not survive.
Microsoft Builds Massive AI 'Super Factory' In Atlanta To Power OpenAI And Elon Musk's xAI
Microsoft Corp (NASDAQ: MSFT) is building an AI super factory in Atlanta to double its data center footprint and keep up with the $400 billion AI industry.
"Tech Prophet" Who Predicted the iPhone Now Predicts... - Ad
George Gilder - who predicted the iPhone 17 years early and gave Reagan the first microchip - is making his boldest call yet. He says an American nanotech "super-convergence" could mint more millionaires than any event in recent memory. He's found 3 stocks set to benefit before November 18's bombshell.
Tesla's First Semi Vehicle Customer After Full Production Launch Is….Tesla?
Tesla Semi is one of several vehicles set for full-scale production in 2026 from Tesla. Here's the company's first major customer.
Meta Stock Continues To Slide: What's Going On?
Meta Platforms Inc (NASDAQ:META) shares are trading lower on Wednesday. Here's everything you need to know.
After 50 Years of Chemo, One Biotech Could Lead the Next Cancer Breakthrough - Ad
For decades, toxic chemotherapy defined cancer care. This biotech's innovative approach could finally change that. With early results showing precision without poison, this story is one investors will want to see early.
How Europe's private drone industry eyes opportunity as NATO strengthens defense
AALBORG, Denmark (AP) — In a warehouse more than 1,500 kilometers (900 miles) from Ukraine's capital, workers in northern Denmark painstakingly piece together . Some of the devices will be exported to Kyiv in the hopes of jamming Russian technology on the battlefield, while others will be shipped across Europe in efforts to combat mysterious drone intrusions into NATO's airspace that have the entire continent on edge.
Best ETF For The Critical Minerals Boom? Here Are Rare Earth Winners
Here's how VanEck's REMX and Amplify's BATT stack up in the fight for dominance over critical minerals and the clean energy supply chain.
The K7 Is Changing the Economics of Security - Ad
$65-an-hour guards can't compete with a $15-an-hour AI machine that never sleeps. The K7 delivers nonstop protection and smarter analytics that improve with every patrol.
China's car sales slow in October as some trade-in subsidies, tax breaks are phased out
BANGKOK (AP) — China's passenger car sales slowed in October, even for electric vehicle makers BYD and Tesla, as automakers cut prices to compete in an overcrowded market, an industry association said Tuesday.
Traders Love This Time Of Year For Broadcom — Here's Why It Rarely Fails
Broadcom stock has gained in 14 of the last 16 mid-November to mid-December periods, with an average return of 8.9%.
Why Wall Street Is Piling Into the "Debasement Trade" - Ad
Wall Street has been making headlines lately for piling into a strange new money move. What they've dubbed the "Debasement Trade"... And it could affect you and your money in a MAJOR way. Dr. David Eifrig's latest warning deserves your attention.
Elon Musk Teases Two More Tesla Diner Locations After Success In California: Here Are The Future Spots
The EV company opened its first Tesla Diner in July. CEO Elon Musk hints that more locations could be coming.
Trump no-show at big Asian economic forum may risk US reputation in region
GYEONGJU, South Korea (AP) — A hot mike caught U.S. President Donald Trump saying that his much-anticipated meeting Thursday , meant to settle the most important trade relationship in the world, would be “three, four hours” and he would then fly back to Washington.
This Overlooked Memecoin Is Showing Early Breakout Signals - Ad
We've been tracking one small memecoin that checks all the boxes: strong on-chain signals, real traction, and an entry point that could offer serious upside. It's not on many radars yet-but that could change fast.
Meta, Alphabet, Chipotle, Microsoft And Starbucks: Why These 5 Stocks Are On Investors' Radars Today
Major stock indexes traded mixed on Wednesday, with the Dow Jones Industrial Average slipping nearly 0.2% to 47,632 and the S&P 500 holding steady at 6,890.59.
Sawyer Merritt Threatens To Move Assets If Charles Schwab Votes Against Elon Musk's Tesla Pay Package: 'I Can't In Good Conscience...'
Sawyer Merritt criticizes Charles Schwab for voting against Musk's $1 trillion pay package, threatening to move assets.
Buy This Stock Tomorrow? - Ad
A renowned former hedge fund manager - friends to some of the biggest investors in the world - just released a new list of his favorite AI stocks... and not a single Magnificent 7 name made the cut. Instead, an AI stock you've likely never heard of just flagged as "near-perfect" in his new investing scoring system.
Nvidia Packaging Partner Amkor Logs Momentum Gain— Up Over 30% YTD On AI Surge
Amkor Technologies (AMKR) hits top momentum percentile, up over 30% YTD as Nvidia's key CoWoS/HBM partner. AI surge drives gains.
Sam Altman Says 'Shame on Me' If OpenAI Doesn't Become 'First Big Company' Run By An AI CEO
Sam Altman, the CEO of OpenAI, has made a bold prediction about the future of the company.
America's Next Security Revolution Has Begun - Ad
Built for endurance, powered by AI, and proven in the field, the K7 is redefining protection for ports, energy hubs, and cities across the nation. The rollout is already underway.
Tempus AI Stock (TEM) Slides 6% Overnight: Here's Why The Stock Is Trending
Tempus AI shares fell 6.02% in after-hours trading Tuesday following its third-quarter earnings report.
Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.